25/09/2025 - Campus Can Ruti, Research

A group of genes could anticipate the response to a key breast cancer treatment

A study coordinated from Badalona by IrsiCaixa, the Catalan Institute of Oncology and the Germans Trias i Pujol Research Institute (within the CARE programme) has identified KIMA, a genomic signature that makes it possible to anticipate which patients with HR+/HER2- breast cancer will respond less well to CDK4/6 inhibitors. The finding, published in the journal Clinical and Translational Medicine, may help personalize therapies and design new combinations.

23/09/2025 - Campus Can Ruti, Innovation, Projects, Success Stories

A project on an innovative tool for cancer surgery, selected in the 2025 CaixaImpulse call

The "la Caixa" Foundation has announced the results of the 2025 call for proposals for its CaixaImpulse program, through which it supports 31 biomedical projects from research centres, hospitals and universities in Spain and Portugal. A project coordinated by IIS IGTP led by Ana Piqueras (HUGTiP) has been selected in the call to continue with the development and implementation of a medical device to find and remove cancer cells more accurately during surgery.

19/09/2025 - Campus Can Ruti, Conferences, Innovation, Success Stories

The Innomed community visits the Immunoassay Technology Center, Werfen’s facilities in Lliçà d’Amunt

On 18 September, around thirty people involved in the Innomed program visited the Werfen facilities in Lliçà d'Amunt (the Immunoassay Technology Center). The meeting provided an opportunity to learn about the company's strategic areas and to establish contacts for exploring possible collaborations.

08/09/2025 - Campus Can Ruti, Institutional, Success Stories

IGTP publishes its 2024 Annual Report, a year of institutional recognition and advances in research

The report, available in its extended format and in summary versions, compiles the institution's activity during 2024 and reflects its growth and consolidation.

04/09/2025 - Campus Can Ruti, Projects, Research, Success Stories

Germans Trias, the first centre in Spain to include a patient in an international study on the early treatment of aortic stenosis

The iCor team at the Germans Trias i Pujol University Hospital and Research Institute is the first in Spain to enrol a patient in the international EASY-AS study, a clinical trial to evaluate whether intervening before the first symptoms of severe aortic stenosis appear can improve clinical outcomes.

26/08/2025 - Campus Can Ruti, Conferences, Success Stories

Can Ruti welcomes patients and families from across Europe as part of the NF Academy 2025

The Germans Trias i Pujol University Hospital and Research Institute welcomed patients and families from several European countries as part of the NF Academy 2025, an event organised by Neurofibromatosis Patients United together with the ACNEFI to train and empower young people living with NF1, NF2-SWN and SWN.

28/07/2025 - Campus Can Ruti, Projects, Research

A community-based action led by IGTP facilitates screening and access to treatment for viral hepatitis among migrant populations in Catalonia

On the occasion of World Hepatitis Day, IGTP presents the results of the HepBClink project, which has combined community educational actions on hepatitis B and C with screening and referral to treatment for migrants from Pakistan, Senegal and Romania. The project has involved the participation of the DxEpiPath group at IGTP and is part of the Tranversal Program CORE.

17/07/2025 - Campus Can Ruti, Research

New insights into heart scar tissue could improve treatment after heart attacks

A team of researchers from the IGTP has taken a step forward in understanding the complex structure of heart scars that form after a myocardial infarction. Using a porcine model, the group found an association between specific electrical patterns and structural characteristics of the scar, offering a new approach that may guide more targeted and effective treatments for arrhythmias. The results have been published in the journal Heart Rhythm.

16/07/2025 - Campus Can Ruti, Research

The Germans Trias Research Institute and ICO Badalona describe genomic alterations that may help predict treatment response in an aggressive type of breast cancer

Researchers at IGTP, HUGTiP and ICO Badalona have identified genetic alterations, including frequent TP53 mutations, that could serve as biomarkers to guide treatment decisions in HER2-positive breast cancer.

15/07/2025 - Campus Can Ruti, Research

The Ibero-American network RIGHT PLUS, coordinated from the Can Ruti Campus, launches LAMIS 2025, a key study on the health of gay, bisexual and other men who have sex with men in Latin America and the Caribbean

The second edition of the LAMIS survey is being coordinated from the Can Ruti Campus. This key international study explores the psycho-socio-sexual health of gay, bisexual and other MSM across 24 countries in Latin America and the Caribbean, with active involvement of the CEEISCAT research group.